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ABSTRACT: Antifreeze (glyco) proteins are produced by
many cold-acclimatized species to enable them to survive
subzero temperatures. These proteins have multiple macro-
scopic effects on ice crystal growth which makes them
appealing for low-temperature applicationsfrom cellular
cryopreservation to food storage. Poly(vinyl alcohol) has
remarkable ice recrystallization inhibition activity, but its mode
of action is uncertain as is the extent at which it can be
incorporated into other high-order structures. Here the
synthesis and characterization of well-defined block copoly-
mers conta in ing poly(v iny l a lcohol) and poly-
(vinylpyrrolidone) by RAFT/MADIX polymerization is
reported, as new antifreeze protein mimetics. The effect of adding a large second hydrophilic block is studied across a range
of compositions, and it is found to be a passive component in ice recrystallization inhibition assays, enabling retention of all
activity. In the extreme case, a block copolymer with only 10% poly(vinyl alcohol) was found to retain all activity, where
statistical copolymers of PVA lose all activity with very minor changes to composition. These findings present a new method to
increase the complexity of antifreeze protein mimetic materials, while retaining activity, and also to help understand the
underlying mechanisms of action.
■ INTRODUCTION
Antifreeze (glyco) proteins (AF(G)Ps) are produced by species
which live in extreme cold environments (i.e., the Earth’s poles
or at high altitude) as an evolutionary adaptation to control the
formation and growth of ice crystals, which would otherwise
lead to death.1 AF(G)Ps have three main effects: IRI (ice
recrystallization inhibition), TH (thermal hysteresis; non-
colligative depression of freezing point), and DIS (dynamic
ice shaping) associated with the protein−ice interactions. IRI is
a particularly interesting property for a range of biotechno-
logical applications which involve cellular cryopreservation, as
ice growth on thawing has been shown to be a key source of
cell death. The ability to control ice growth would also be
useful in industrial settings including aircraft wings, wind
turbines, and food storage or in the space industry.2−5
AF(G)Ps themselves are not always suitable for application
due to potential toxicity issues and the price of scale up,
especially for AFGPs which cannot easily be expressed
recombinantly in bacteria (due to the need for glycosylation).6
A particular problem with AF(G)Ps when applied to
cryopreservation is the onset of DIS, which reduces cell
recovery due to the formation of spicular ice which pierces cell
membranes.7 Ben et al. have developed low molecular weight
peptides and glyco-mimetics which show selective IRI activity
and enhanced cryopreservation.8,9 Crucially, these simplified
structures show that reductionist approaches to mimicking
AF(G)P function are plausible and that new structures can
selectivity show one AF(G)P “antifreeze” property rather than
all three, with the implication that multiple molecular
mechanisms may be in action.10 Native AFPs show different
levels of TH and IRI with the two properties not always
correlated.11,12
Inspired by this, we have shown that synthetic polymers can
mimic AF(G)P’s IRI activity, even though they lack the precise
secondary/tertiary structure which is essential for AF(G)P
function.5 These have been applied to enhance the
cryopreservation of blood13−15 and somatic cells16 but retain
low cytotoxicity. Polymer mimetics have the advantage of being
scalable and highly tunable in terms of composition and
architecture. Additionally, native AFGPs show an increase in
activity as the highly repetitive glyco-tripeptide motif is
elongated,1 implying that synthetic polymers which can easily
have their molecular weight tuned could have enhanced
activity. The most potent polymeric AF(G)P mimetics
identified thus far are those based on poly(vinyl alcohol),
PVA, which inhibits all ice growth at sub mg·mL−1
concentrations. PVA also has well-known biocompatibility
and is used in a range of medical or food applications.17
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Polyampholytes (with mixed positive/negative side groups)
have also been developed by Matsumura et al., which are potent
cryoprotectants18−20 despite having less IRI,21 demonstrating
the complex relationship between inhibiting ice growth and
cellular cryopreservation.
Key questions still exist about the mode of action of PVA
polymers, especially to understand if ice binding is occurring, or
if they function at the quasi-liquid layer at the ice/water
interface and slow down the exchange of water between ice
grains. This latter mechanism does not require ice binding, and
also explains the lack of (or very weak) TH and DIS activity
observed with most PVAs. Budke and Koop suggested that the
spacing of hydroxyl groups in PVA precisely matches a single
crystal face of ice and have observed ice shaping.22 However,
this study used high molecular weight PVA (27 kg mol−1) with
large molecular weight dispersity, making it unclear as to which
molecular weight fractions were responsible for the activity. We
addressed this using reversible addition−fragmentation chain
transfer (RAFT) polymerization23 to obtain well-defined PVAs
from 800 to 20000 g·mol−1. Quantitative IRI studies showed
that even DP 10 PVAs had activity but that a significant
enhancement occurred at DP 20.24 For these shorter polymers,
no TH or DIS was observed which suggests that ice binding is a
molecular weight dependent effect. Addition of comonomers
with PVA (or residual acetate groups from the synthesis)
removed all activity from the PVA, suggesting that it is not
tolerant of modifications and potentially supporting the ice
binding hypothesis.24 To address this, we have investigated
(supramolecular) branched PVAs and found that addition of a
third arm to a PVA has no effect on IRI activity,25 as has been
seen for branched AFPs.26 This is significant, as although the
molecular weight was increased, there was no enhancement
compared to increasing the molecular weight of a linear
polymer. Brush-like PVA also shows identical activity to linear
equivalents12 despite having far higher molecular weight.
The role of an additional (chemically different) block on the
IRI activity of a polymer has not been studied in detail but
could provide an alternative approach to increase the
functionality such as increasing blood circulation lifetime or
to enable incorporation into polymer composites or as protein
conjugates.27 Interestingly, AFP−fusion proteins retain or even
have enhanced activity28 and many antifreeze proteins are
already tagged with, e.g., a His-tag to enable purification via
nickel affinity chromatography, supporting this hypothesis.
Mastai and Baruch studied branched poly(ethylene oxide)−
poly(ethylenimine) block copolymers with polyglycidol side
chains for ice interactions by DSC, observing some impact of
the copolymer structure, but only DSC was used to probe
this.29 Antonietti and co-workers found that phosphorylated
poly(ethylene oxide)-block-poly[2-(2-hydroxyethyl) ethylene]
had some IRI activity but only at high concentrations of 30 mg·
mL−1.30 There has not been a detailed structure−activity study
on block copolymer structure and ice growth inhibition, in part
due to the challenges of polymerizing lesser activated
monomers such as vinyl acetate (where poly(vinyl acetate) is
the precursor to PVA) using RAFT CRP, although cobalt31 and
vanadium mediators have been reported to give excellent
control over Vac polymerizations.32
Controlled radical polymerization affords straightforward
routes to preparing block copolymers as, due to the inherent
living nature of the reaction, polymerizations are not
irreversibly terminated. Using the RAFT/MADIX (reversible
additional transfer fragmentation/macromolecular design via
interchange of xanthates) methodology, vinyl acetate can be
effectively polymerized, but there are few other monomers with
which it undergoes effective (block) copolymerization. Stenzel
and co-workers used MADIX to polymerize N-vinylpyrrolidone
(NVP), examining chain extension using vinyl acetate, and
accessing NVP star polymers.33 This has also been demon-
strated by Okamoto and co-workers, using a benzyl and o-
ethoxy functional MADIX agent in fluoroalcohols.34 Klumper-
man and co-workers also published several reports on the
preparation of NVP-containing block copolymers35,36 demon-
strating that PVA blocks can be accessed.
To address the questions around block copolymer
architecture on IRI activity, this manuscript reports a detailed
study on the effect of block copolymer architecture on PVA’s
IRI activity compared to previous work where statistical
copolymerization was used leading to a loss in activity.24 A
library of vinylpyrrolidone block copolymers were synthesized,
and the role of each block is evaluated by a quantitative IRI
assay. Remarkably, PVA activity is shown to be tolerant to PVP
inclusion, even at very high PVP weight percentages, which may
support a mechanism not based entirely on ice binding.
■ EXPERIMENTAL SECTION
General. Phosphate-buffered saline (PBS) solutions were prepared
using preformulated tablets (Sigma-Aldrich) in 200 mL of Milli-Q
water (>18.2 Ω mean resistivity) to give [NaCl] = 0.138 M, [KCl] =
0.0027 M, and pH 7.4. Vinyl acetate and N-vinylpyrrolidone were
purchased from Sigma-Aldrich and were filtered through a plug of
basic alumina to remove inhibitors prior to their use. 4,4′-Azobis(4-
cyanovaleric acid) was recrystallized from methanol and stored at −8
°C in the dark. Hydrazine hydrate solution (80%) was purchased from
Sigma-Aldrich. All solvents were purchased from VWR or Sigma-
Aldrich and used without further purification, except for 1,4-dioxane,
which was filtered through a plug of alumina prior to use.
Physical and Analytical Methods. 1H and 13C NMR spectra
were recorded on Bruker DPX-300 and DPX-400 spectrometers using
deuterated solvents obtained from Sigma-Aldrich. Chemical shifts are
reported relative to residual nondeuterated solvent. Mass spectral
analyses were obtained using Bruker MicroTOF or Bruker MaXis
electrospray instruments using positive or negative electrospray mode.
The molecular ion and mass fragments are quoted and assigned. Gel
permeation chromatography (GPC) was used to determine the
molecular weights and dispersity of the synthesized polymers. The
THF GPC system was comprised of a Varian 390-LC-Multi detector
suite fitted with differential refractive index (DRI), light scattering
(LS), and ultraviolet (UV) detectors equipped with a guard column
(Varian Polymer Laboratories PLGel 5 μm, 50 × 7.5 mm) and two
mixed D columns of the same type. The mobile phase was THF with
5% trimethylamine (TEA) eluent at a flow of 1.0 mL/min, and
samples were calibrated against Varian Polymer Laboratories Easi-Vials
linear poly(styrene) and poly(methyl methacrylate) standards (162−
2.4 × 105 g mol−1) using Cirrus v3.3. The DMF GPC system was
comprised of a Varian 390-LC-Multi detector suite fitted with a
differential refractive index (DRI) detector equipped with a guard
column (Varian Polymer Laboratories PLGel 5 μm, 50 × 7.5 mm) and
two mixed D columns of the same type. The mobile phase was DMF
with 5 nM NH3BF4 eluent at a flow of 1.0 mL·min
−1, and samples
were calibrated against Varian Polymer Laboratories Easi-Vials
poly(methyl methacrylate) standards (162−2.4 × 105 g mol−1) using
Cirrus v3.3. Ice wafers were annealed on a Linkam Biological
Cryostage BCS196 with T95-Linkpad system controller equipped with
an LNP95-Liquid nitrogen cooling pump, using liquid nitrogen as the
coolant (Linkam Scientific Instruments UK, Surrey, UK). An Olympus
CX41 microscope equipped with a UIS-2 20×/0.45/∞/0−2/FN22
lens (Olympus Ltd., Southend on sea, UK) and a Canon EOS 500D
SLR digital camera was used to obtain all images. Image processing
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was conducted using ImageJ, which is freely available from http://
imagej.nih.gov/ij/.
Polymerization of N-Vinylpyrrolidone. As a representative
example, N-vinylpyrrolidone (2.09 g, 18.78 mmol), CTA 1 (0.037 g,
0.17 mmol), and ACVA (0.005 g, 0.02 mmol) were dissolved in
dioxane (4 mL) in a stoppered vial equipped with a stir bar. The
reaction mixture was thoroughly degassed by bubbling N2 through the
solution for 20 min, and the reaction mixture was allowed to
polymerize at 70 °C for typically 3 h. The dark yellow solutions were
then cooled to room temperature, and the block copolymer was
recovered as white flakes by precipitation into cold diethyl ether held
under ice. The bulk of the solvent was carefully decanted and the solid
collected by centrifugation. The product was thoroughly dried under a
vacuum at 40 °C for 24 h, forming a yellow solid. Representative
characterization data for PVP55:
1H NMR (400 MHz, CDCl3) δ 3.74
(−CHN−, br, 1H), 3.19 (−NCH2CH2−, br, 2H), 2.38 (−NCOCH2−,
br, 2H), 2.21(−NCH2CH2CH2−, br, 2H), 1.81−1.53 (−CH2−, br,
2H); Mn
SEC(THF) = 3350 Da, Mw/Mn = 1.42.
Chain Extension of Poly(vinylpyrrolidone) macroCTA with
Vinyl Acetate. As a representative example, PVP macroCTA (0.158
g, 2.6 × 10−5 mol), vinyl acetate (1.12 g, 13 × 10−3 mol), dioxane (2.6
mL), and ACVA (4,4′-azobis(4-cyanovaleric acid); 0.001 g, 4.2 × 10−6
mol) were added to a stoppered vial. The solution was thoroughly
degassed by bubbling N2 through the solution for 20 min, and the
reaction mixture was then allowed to polymerize at 68 °C for 12 h.
The yellow solutions were then cooled and opened to air. The block
copolymer was then recovered as a yellow sticky solid after
precipitation into diethyl ether. The diethyl ether was then decanted
and the block copolymer was redissolved in THF, which was then
concentrated in vacuo and thoroughly dried under a vacuum at 40 °C
for 24 h, forming a yellow solid. Representative characterization data
for PVAc18-b-PVP55:
1H NMR (400 MHz, CDCl3) δ 4.61
(−CHOAc−, br, 1H), δ 3.74 (−CHN−, br, 1H), 3.19 (−NCH2CH2−,
br, 2H), 2.38 (−NCOCH2−, br, 2H), 2.21(−NCH2CH2CH2−, br,
2H), δ 2.00 (−CH3, t, 3H), 1.81−1.53 (−CH2−, br, 2H); MnSEC
(DMF) = 9130 Da; Mw/Mn = 1.36.
Polymerization of Vinyl Acetate. As a representative example,
CTA (5.2 mg, 2.6 × 10−5 mol), vinyl acetate (4.67 g, 2.6 × 10−3 mol),
and ACVA (4,4′-azobis(4-cyanovaleric acid); 0.0013 g, 4.6 × 10−6
mol) were added to a stoppered vial. The reaction mixture was
thoroughly degassed by bubbling N2 through the solution for 20 min,
and the reaction mixture was then allowed to polymerize at 68 °C for
10−30 min, depending on the desired degree of conversion (at 1/100
[CTA]/[monomer] conversion = 1% /min). The yellow solutions
were then quenched in liquid nitrogen and exposed to air. The
polymer was then recovered as a yellow sticky solid after precipitation
into hexane. The hexane was then decanted and the poly(vinyl
acetate) redissolved in THF, which was then concentrated in vacuo
and thoroughly dried under a vacuum at 40 °C for 24 h, forming a
yellow solid. Representative characterization data for PVAc30:
1H
NMR (400 MHz, CDCl3) δ 4.61 (−CHO−CH2, br, 1H), 1.74
(−CO−CH3, br, 3H), 1.53 (−CH2−, br, 2H); MnSEC(THF) = 2642
Da, Mw/Mn = 1.12.
Chain Extension of Poly(vinyl acetate) macroCTA with N-
Vinylpyrrolidone. As a representative example, PVAc macroCTA
(0.307 g, 1.16 mmol), N-vinylpyrrolidone (3 g, 28.2 mmol), dioxane
(0.5 mL), and ACVA (4,4′-azobis(4-cyanovaleric acid); 0.028 g, 1 ×
10−4 mol) were added to a stoppered vial. The reaction mixture was
thoroughly degassed by bubbling N2 through the solution for 20 min,
and the reaction mixture was then allowed to polymerize at 70 °C for
12 h. The yellow solutions were then cooled and opened to air. The
block copolymer was then recovered as a yellow sticky solid after
precipitation into diethyl ether. The diethyl ether was then decanted
and the block copolymer redissolved in THF, which was then
concentrated in vacuo and thoroughly dried under a vacuum for 24 h,
forming a pale yellow solid. Representative characterization data for
PVAc30-b-PVP24:
1H NMR (400 MHz, CDCl3) δ 4.61 (−CHOAc−,
br, 1H), δ 3.74 (−CHN−, br, 1H), 3.19 (−NCH2CH2−, br, 2H), 2.38
(−NCOCH2−, br, 2H), 2.21(−NCH2CH2CH2−, br, 2H), δ 2.00
(−CH3, t, 3H), 1.81−1.53 (−CH2−, br, 2H); MnSEC (THF) = 5376
Da; Mw/Mn = 1.16.
Hydrolysis of PVAc-b-PVP Block Copolymers. As a representa-
tive example, PVAc30-b-PVP24 (0.3 g, 5376 Da, Mw/Mn = 1.16) was
dissolved in a methanol (2 mL) and hydrazine hydrate solution (5 mL,
80% in water) in a stoppered vial. The reaction mixture was stirred at
60 °C for 5 h. The reaction mixture was then dialyzed using distilled
water, and PVA30-b-PVP24 was recovered as a spongy white solid by
freeze-drying the dialysis solution. Complete hydrolysis was confirmed
by 1H NMR. Representative characterization data for PVA30-b-PVP24:
1H NMR (400 MHz, D2O): δ = 3.52 (−CHN−, br d, 1H), δ = 4.00
(−CHO−, br, 1H), δ = 3.12 (−NCH2CH2−, br d, 2H), δ = 2.49
(−NCOCH2−, br, 2H), δ = 2.13 (−NCH2CH2CH2−, br d, 2H), δ =
1.80−1.50 (−CH2−, br, 2H).
■ RESULTS AND DISCUSSION
The key aim of this study was to investigate if block copolymers
of PVA would retain or lose their potent IRI activity, as all
other modifications to the PVA structure have been reported to
result in a complete loss of activity.24 These prior observations
raise questions about the mode of action and limit its
translation into applications, but they also create the
opportunity to use macromolecular architecture to modulate
activity. To introduce a second water-soluble block, poly-
(vinylpyrrolidone) (PVP) was selected as it is compatible with
the same xanthates required for PVA, which will allow
reinitiation and hence block copolymerization (vide inf ra).
The chain transfer agent (xanthate) was synthesized according
to previous reports and is detailed in the Supporting
Information. RAFT/MADIX was conducted in dioxane
Table 1. PVP macroCTAs Prepared for This Study
macro CTA [M]:[CTA]a conv.b (%) Mn,NMR
c (g mol−1) Mn,SEC
d (g mol−1) Mw/Mn
d DPn
e DPn
f
PVP30 50 60 3350 1700 1.46 15 30
PVP55 100 30 6110 3350 1.42 30 55
PVP70 100 38 7780 3840 1.42 35 70
aMonomer to RAFT agent ratio. [M] = 2 M in 1,4-dioxane. bDetermined by 1H NMR spectroscopy. cDetermined by 1H NMR of PVP after
precipitation and drying. dDetermined by SEC. eNumber-average degree of polymerization from SEC. fNumber-average degree of polymerization
from 1H NMR.
Scheme 1. Preparation of PVP macroCTA
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(Scheme 1), at various [monomer]:[CTA] ratios, isolated and
characterized by 1H NMR and SEC, Table 1.
As previously reported, the SEC Mn values obtained for PVP
are underestimated, as DMF (or other standard SEC solvents)
is not an ideal solvent for it, but dispersity values around 1.4
were observed, as would be expected for this monomer by
RAFT/MADIX.37,38 1H NMR end-group analysis enabled
estimation of the molecular weight by comparing the aromatic
end-groups to the main chain, which were in agreement with
that predicted from the conversion. From this point on, the
NMR degree of polymerization will be the stated value. With
these macro-CTAs on hand, reinitiation using vinyl acetate as
the monomer was conducted (Scheme 2) and the following
block copolymers were isolated and characterized, Table 2.
Acceptable dispersity and monomodal distributions were
obtained (Supporting Information), indicating quantitative
reinitiation and no evidence of unreacted homopolymer.
Hydrazinolysis was used to quantitatively remove the acetate
protecting groups, confirmed by infrared spectroscopy and 1H
NMR (see the Supporting Information).
With this panel of polymers on hand, their IRI activity could
be tested. This was done using the ‘splat’ assay. Briefly, 10 μL
droplets of the polymers in phosphate buffered saline (PBS)
were dropped onto a glass coverslip that sat on a chilled (−80
°C) aluminum plate. This generates a large number of <10 μm
ice crystals by rapid nucleation. This is then transferred to a
cold stage set at −8 °C and the ice crystal size measured after
30 min, enabling only growth (or inhibition of growth) to be
measured. Data is reported relative to a PBS control, with
smaller numbers indicating more activity. Control experiments
confirmed that PVP homopolymers are nonactive. To enable a
critical comparison of PVA activity, all data is reported as the
PVA concentration in solution, not the total polymer
concentration, to enable the effect of the second block to be
probed and the results are shown in Figure 1.
Table 2. PVA-b-PVP Block Copolymers
PVAc-b-PVP [M]/[mCTA]a conv.b (%) Mn,NMR
c (g mol−1) Mn,SEC
d (g mol−1) Mw/Mn
d PVAce DP (−)
PVAc20-b-PVP30 20 96.8 5050 3400 1.47 20
PVAc18-b-PVP55 500 15.6 7650 5400 1.35 18
PVAc32-b-PVP70 1000 11.2 10520 9130 1.36 32
PVAc37-b-PVP70 2000 6.1 10950 9650 1.38 37
a[Total monomer]/[RAFT agent] ratio; polymerizations conducted in 2 M monomer solutions in dioxane. bDetermined by 1H NMR spectroscopy.
Theoretical Mn determined from the monomer to RAFT agent ratio.
cDetermined by 1H NMR of the copolymers after precipitation and drying.
dDetermined by SEC in DMF using PMMA standards. eDetermined by 1H NMR spectroscopy of the PVP-b-PVAc block copolymers.
Scheme 2. Preparation of PVA-b-PVP Block Copolymer
Figure 1. Ice recrystallization inhibition activity of PVA-b-PVP block
copolymers. (A) Activity derived from splat test. (B) Example ice
wafer of PBS alone. (C) Ice wafer of 1 mg·mL−1 of PVA32-b-PVP70.
MLGS = mean largest grain size relative to a PBS control, expressed as
%. Error bars represent the standard deviation from at least three
measurements.
Figure 2. Comparison of sequence distribution on ice recrystallization
inhibition activity. PVA70-rand-PVP20 random copolymer from
previous work24 (Mn = 4320, Đ = 1.33, PVA = 48 wt %). Cartoons
for PVA (blue) and PVP (black) are intended as a guide to structure
only. MLGS = mean largest grain size relative to a PBS control,
expressed as %. Error bars represent the standard deviation from at
least three measurements.
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In line with our earlier work,24 the PVA containing polymers
all showed remarkably strong IRI activity, comparable to that of
native antifreeze proteins. In all cases, even with large PVP
blocks, IRI activity was retained with the longer (DP 32) PVAs
being more active than shorter ones (DP = 20), highlighting
the crucial molecular weight dependence of this property.
Considering the large size of the PVP component, it is
somewhat surprising that activity was not affected. An
additional series of experiments was conducted to compare
block copolymer versus random copolymers to ascertain the
role of sequence. A polymer was synthesized containing just 20
PVP and 70 PVA and tested for IRI, Figure 2. DP 70 PVA
should be a very potent IRI, but the addition of the PVP units
removed activity. In comparison, a DP 20 PVA as a homo or
block copolymer retained all activity, again highlighting that the
macromolecular architecture, not just the composition, is
crucial for these polymers. One current hypothesis for the
disruption of activity in copolymers is that unbroken sequences
of hydroxyl groups are required for ice binding. This is
discussed later in the manuscript.
The above data provided some insight into the role of a
second block on PVA activity. However, the synthesis method
of the PVP first meant that each PVA block was slightly
different in length and dispersity which might conflict with the
interpretation. As IRI activity is very sensitive to PVA block
length in this regime, the synthetic strategy was revised, to
synthesize the PVA blocks first, with predefined lengths, and to
use these in a series of reinitiation experiments using PVP,
Scheme 3. This ensured that the PVA component is identical
across the series for a more systematic approach. Two PVAs
were synthesized with a DP of 10 and 30, Table 3. These
lengths were chosen, as the DP range of 10−30 is where the
most significant changes in PVA’s IRI activity have been seen.
The macro-CTAs were then used for subsequent chain
extension with PVP, and the acetate groups removed by
hydrazinolysis, Table 4. As with the homo-PVPs, the SEC
molecular weights were lower than expected, and NMR values
were used.
Scheme 3. Preparation of PVAc macroCTA
Table 3. Initial PVAc Homopolymers Prepared for This Study
entry [M]:[CTA]a convb (%) Mn,Theo
c (g mol−1) Mn,NMR
d (g mol−1) Mn,SEC
e (g mol−1) Mw/Mn
e DPn
f
PVAc30 100 24.2 8610 2670 2640 1.12 30
PVAc10 100 10 1056 780 920 1.32 9
aMonomer to CTA ratio. bDetermined by 1H NMR spectroscopy. cTheoretical Mn determined from the monomer to RAFT agent ratio.
dDetermined by 1H NMR spectroscopy. eDetermined by SEC in THF using PMMA standards. fNumber-average degree of polymerization.
Table 4. PVAc10-b-PVP Block Copolymers Prepared for This Study
PVAc-b-PVP [M]/[CTA]a NVP (mL) conv.b (%) Mn,NMR
c (g mol−1) Mn,DMF
d (g mol−1) Mn,THF
e (g mol−1) Mw/Mn
d
PVA30-b-PVP60 240 3 18.3 4730 5380 N/A 1.16
PVA10-b-PVP27 10 0.75 18.3 1970 3080 570 1.37
PVA10-b-PVP90 30 1.90 100 4190 4600 740 1.59
PVA10-b-PVP72 50 3.79 56.8 3640 7479 760 1.76
PVA10-b-PVP85 75 5.78 43.2 3970 10060 690 1.99
a[Total monomer]/[RAFT agent] ratio; polymerization conducted in 5 mL of 1,4-dioxane and varying concentrations of N-vinylpyrrolidone.
bDetermined by 1H NMR spectroscopy. cDetermined by 1H NMR of the copolymers after precipitation and drying. dDetermined by SEC in THF
using PMMA standards. eDetermined by 1H NMR spectroscopy of the PVAc-b-PVP block copolymers.
Figure 3. Effect of PVP block on ice recrystallization inhibition activity
of PVA30. Concentration reported is correct to PVA concentration not
total polymer concentration. MLGS = mean largest grain size relative
to a PBS control, expressed as %. Error bars represent the standard
deviation from at least three measurements.
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Figure 3 shows the results of the IRI testing of DP 30 PVA
homopolymer and following two different chain extensions
with PVP. The data shows remarkably good correlation with
the PVA-weighted activity, being statistically identical in all
cases, confirming that addition of a large, hydrophilic addition
block does not disrupt function when using this length of PVA.
The shorter DP 10 polymers were also tested. DP 10 PVA
has significantly lower IRI activity (but still far more than other
synthetic IRIs) than those with DP > 20, making it a more
stringent test for the impact of chain extension. Four different
PVP block lengths were tested and compared to DP 10 PVA
and reported as a function of PVA concentration. In line with
the data above, activity was retained in all cases with there being
no statistically significant differences between any of the
individual block copolymers compared to the homopolymer.
The only exception to this was PVA10 and PVA10-b-PVP72.
The block copolymer appears to have slightly higher activity
but only in a rather narrow concentration range which we are
hesitant to explain as an enhancement as the activity plateaus to
a similar level.
The data presented above demonstrates that although main
chain modifications to IRI active polymers are not tolerated
additional functionality can be easily included via block
copolymerization. We have recently observed that with
supramolecular star-branched PVAs where addition of a third
arm does not provide additional activity, relative to a pseudo-
two-armed equivalent (a linear polymer).25 This is in
agreement with these findings, which can enable some insight
into the potential mechanisms of action. Native antifreeze
proteins appear to function by direct interaction with specific
faces of growing ice crystals, leading to thermal hysteresis and
dynamic ice shaping. For these polymers, we see no evidence of
ice shaping. Ben et al. have studied several small molecule IRI
active compounds and found IRI without any TH or DIS and
using solid state NMR have found evidence that disruption of
the quasi liquid layer interface may be the crucial mechanism of
action to obtain IRI without ice binding.39 There is also
speculation that PVA’s activity is due to its specific hydroxyl
group spacing interfacing with the ice crystals, and hence
disruption of the PVA primary sequence (as a copolymer, for
example) reduces activity. In the case of PVA10-b-PVP90, over
90% of the polymer is PVP, shown in a space filling model in
Figure 4B. Such a large modification would be expected to
dramatically affect the polymer’s ability to bind ice if that was
the dominant mechanism of action. Davies et al. have shown
that conjugation of a 7 kDa AFP to a much larger maltose-
binding protein (42 kDa) is not only tolerated but can enhance
TH activity and suggests AFP−AFP contact (cooperativity) is
not crucial for TH activity.28 The difference here is that these
short PVAs do not show TH nor ice shaping and hence major
structural changes maybe have different effects. If the PVA is
acting on bulk water or the ice/water interface, the PVP “tail”
would simply be dissolved in the liquid water fraction, perhaps
explaining why it has no effect on IRI activity. The passive
nature of the PVP block also rules out viscosity as being crucial
for IRI; for any polymer, increasing the molecular weight
dramatically increases their solution viscosity, which could slow
the rate of water exchange. However, the long PVP chains did
not increase activity, despite these polymers having higher
viscosity relative to PVA homopolymers or shorter block
copolymers. Recent studies on native AFPs have revealed an
ice-like hydration layer on the antifreeze protein surfaces, which
directs the interaction with ice; such a mechanism cannot be
ruled out here.40 While not conclusive evidence, these findings
could support the hypothesis that ice growth inhibiting
polymers (or molecules) may not have the same molecular-
level mechanism as antifreeze proteins, even though they give
rise to similar macroscopic effects. The data presented here on
relatively short PVAs also may not scale with high molecular
weight PVAs (which are extremely challenging to access using
controlled radical polymerization), where ice shaping and
thermal hysteresis is reported22 and the key dependence on
unbroken hydroxyl units also suggests some specific inter-
actions, which will form the basis of future studies.
■ CONCLUSIONS
Antifreeze proteins and glycoproteins are complex macro-
molecules which enable life to survive at extreme low
temperatures, but their mechanism of action, and the
mechanism of action of their synthetic mimics, is not
understood. Here a detailed study in the influence of block
copolymer structure on the ice recrystallization inhibition
activity is presented. Using RAFT/MADIX polymerization, a
library of well-defined polymers were obtained, and for the first
time, chain extension of vinylpyrrolidone from a poly(vinyl
acetate) macromonomer was demonstrated. Full character-
ization of the polymers confirmed monomodal distributions
and full reinitiation of the first block. Quantitative ice
recrystallization inhibition analysis on this library revealed
that addition of the PVP block was essentially passive; it did not
increase or decrease activity. Polymers synthesized with the
extreme composition of only 10% PVA and 90% PVP retained
activity statistically identical to that of PVA homopolymers.
These observations are important, as all previous reports on
Figure 4. (A) PVA weight % dependent IRI activity of PVA10-b-PVP
block copolymers compared to PVA10 (Mn = 440, Đ = 1.18). MLGS =
mean largest grain size relative to a PBS control, expressed as %. Error
bars represent the standard deviation from at least three measure-
ments. (B) Space-filling model highlighting the small amount of PVA
present in the block copolymer. Generated using Chem3D 15.1, this
cartoon is for illustrative purposes only.
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structural modifications of ice recrystallization inhibition active
polymers resulted in a loss of activity. The observations with
block copolymers show that macromolecular architecture could
be a powerful tool to incorporate additional functionality into
these polymers, for example, to increase circulation times in
vivo, or to enable them to be conjugated to other macro-
molecules to create hybrid materials. The lack of influence of
the PVP blocks also gives some insight into the mechanism of
action of PVA and its interaction with ice, or the ice/water
interface. The additional steric bulk of a PVP block would be
expected to influence the interaction with ice (either positively
or negatively), but the passive nature might confirm that PVAs
(at least at the low molecular range being used here) tend to act
at the interface rather than on the ice crystal surface, but further
detailed studies are needed to confirm any of these
mechanisms. In summary, this work represents the first
quantitative and systematic study into block copolymer
structure on IRI activity and will have implications both in
polymer mimetics and also in the rational design of de novo
antifreeze peptides/proteins. These results not only raise hope
that ice inhibiting polymer can be incorporated into more
complex structures for advanced application but also gives some
insight into the mechanisms of ice growth.
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